Natali, A.

Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR)

Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 898

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review

Natali, A., & Ferrannini, E. (2006) · Diabetologia

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 377

Metformin Effects on the Heart and the Cardiovascular System: A Review of Experimental and Clinical Data

Nesti, L., & Natali, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 211

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

Ferrannini, E., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Nolan, J., Walker, M., Natali, A., & Beck-Nielsen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 193

Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM

Bonadonna, R. C., Bonora, E., Prato, S. D., Saccomani, M. P., Cobelli, C., Natali, A., Frascerra, S., Pecori, N., Ferrannini, E., Bier, D., et al. (1996) · Diabetes

Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 191

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”

Pugliese, G., Penno, G., Natali, A., Barutta, F., Di Paolo, S., Reboldi, G., Gesualdo, L., & De Nicola, L. (2019) · Nutrition, Metabolism and Cardiovascular Diseases

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 156

Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance

The RISC Investigators, Mari, A., Tura, A., Natali, A., Laville, M., Laakso, M., Gabriel, R., Beck-Nielsen, H., & Ferrannini, E. (2010) · Diabetologia

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 120

A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants

Wood, A. R., Jonsson, A., Jackson, A. U., Wang, N., van Leewen, N., Palmer, N. D., Kobes, S., Deelen, J., Boquete-Vilarino, L., Paananen, J., et al. (2017) · Diabetes

Genetic Associations and EpidemiologyPancreatic function and diabetes

Cited by 117

Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study

on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 80

Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions

Tricò, D., Filice, E., Trifirò, S., & Natali, A. (2016) · Nutrition & Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 47